off brand tirzepatide Patients struggle to get weight loss drug ahead of price rise Not all GLP-1s are created

FDA labeling for Wegovy (semaglutide) lists common adverse reactions such as nausea, vomiting, diarrhea, constipation, abdominal pain, reflux/GERD, abdominal distension, and flatulence

Ezzeddine, D., Jit, R., Katz, N., Gopalswamy, N

Support is also available through the contact number listed inside the dashboard

In fact, people who experience some nausea often see faster initial weight loss because the medication is effectively reducing appetite and slowing digestion

Real-world data suggests comparable weight loss outcomes between oral and injectable semaglutide when doses are optimized, though individual results vary more with oral formulations